News
Great Atlantic Completes Hole One Extends The Jacklyn North Zone By 50 Meter Hit Multiple Intervals of Quartz Veining - Assays Pending Central Newfoundland
VANCOUVER, British Columbia, November 11th 2020 – GREAT ATLANTIC RESOURCES CORP. (TSXV.GR) (the “Company” or “Great Atlantic”) is pleased to announce it has completed the first hole of the
Guidewire InsuranceSuite Positioned as a Leader in the Gartner Magic Quadrant for P&C Core Platforms, North America, for Sixth Consecutive Time
Guidewire Software, Inc. (NYSE: GWRE), the platform P&C insurers trust to engage, innovate, and grow efficiently, today announced InsuranceSuite has again been recognized as a Leader in the
State Street Expands MediaStats Offering with Central Bank and Thematic Indicators
State Street Corporation (NYSE:STT) today announced the launch of State Street MediaStats Central Bank Indicators and State Street MediaStats Thematic Indicators - two new quantitative investment
Guidewire InsuranceNow Named a Challenger in the Gartner Magic Quadrant for P&C Core Platforms, North America, for Fourth Consecutive Year
Guidewire Software, Inc. (NYSE: GWRE), the platform P&C insurers trust to engage, innovate, and grow efficiently, today announced that InsuranceNow has been named to the Challengers quadrant in the
Uranium Energy Corp Applauds Historic Draft Bipartisan Senate Funding Measure for the Formation of a U.S. Uranium Reserve
Corpus Christi TX, November 11, 2020 - Uranium Energy Corp. (NYSE American: UEC; “UEC” or the “Company”) is pleased to report the Senate Committee on Appropriations has released drafts of
Genprex to Participate in Panel at Life Sciences Summit on November 17
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced
Lineage Cell Therapeutics Completes Patient Enrollment in Phase 1/2a Clinical Study of OpRegen® Cell Therapy for the Treatment of Dry Age-related Macular Degeneration
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing three novel cell therapies for serious conditions, today announced the successful
Zix Sets November 2020 Financial Conference Schedule
Zix Corporation (Zix) (NASDAQ: ZIXI), a leading provider of cloud email security, productivity and compliance solutions, is scheduled to participate at the following virtual financial conferences
VictoryShares® Expands Suite of Thematic ETFs
Victory Capital Holdings, Inc. (NASDAQ: VCTR) (“Victory Capital” or the “Company”) today announced that it has launched the VictoryShares Top Veteran Employers ETF (VTRN) and the VictoryShares
COVID-19 Raises Anxiety Levels for College Students by Presenting Extraordinary Health and Financial Challenges
AIG Retirement Services, a leading retirement plan provider for tax-exempt and public sector employers including education institutions, and EVERFI, the nation’s leading social impact education
Havn Life Announces Launch of a Range of Natural Health Products
The 7 initial formulations are designed to support and enhance memory and brain function, the immune system, energy levels, and overall wellness, while reducing the negative impacts of
Novocure Receives CE Mark for NovoTTF-100L™ System
Novocure (NASDAQ: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer, today announced that it has received the CE Mark for the NovoTTF-100L
Summa Silver Plans Minimum of 15,000 m of Drilling in 2021 around the Consolidated Mine at the High-Grade Silver and Gold Mogollon Property, New Mexico
November 11, 2020 – Summa Silver Corp. (“Summa” or the “Company”) (CSE: SSVR) (OTCQB: SSVRF) (Frankfurt: 48X - https://www.commodity-tv.com/play/summa-silver-rediscovering-historic-belmont-si
Deciphera Presents Updated Preliminary Data from DCC-3014, its CSF1R Inhibitor Program, in Tenosynovial Giant Cell Tumor Patients at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), today announced the presentation of encouraging preliminary results from the ongoing Phase 1/2 study of DCC-3014, a highly selective, oral
CI Financial Enters 12th U.S. RIA Transaction of 2020; Agreement to Acquire US$2.7-Billion Roosevelt Investments Brings Total Projected U.S. Wealth Assets to Approximately US$16.5 Billion
CI Financial Corp. (“CI”) (TSX: CIX) and The Roosevelt Investment Group, Inc. (“Roosevelt”) today announced an agreement under which CI will acquire 100% of Roosevelt, a New York-based registered
Deciphera Presents Data from QINLOCK® (Ripretinib) Program at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), today announced data presentations from clinical studies of QINLOCK, the Company’s switch-control tyrosine kinase inhibitor approved in the U.S. for
More Than 75 Companies Adopt Veeva Vault CTMS to Accelerate Clinical Research
As the need to improve efficiency and speed in trials grows, more than 75 organizations, including six of the top 20 pharmaceutical companies, are unifying clinical information and processes with
Pfizer Announces Positive Results from Fifth Phase 3 Trial of Abrocitinib, Evaluating Safety and Efficacy Across Different Dosing Regimens
Pfizer Inc. (NYSE: PFE) announced today positive top-line results from the Phase 3 JADE REGIMEN study. This 52-week study investigated abrocitinib, an investigational oral once-daily Janus kinase 1
Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2
Pfizer (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that they have reached an agreement with the European Commission to supply 200 million doses of their investigational BNT162b2
ICON Releases First Environmental, Social and Governance Report
ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health
NanoString Highlights Growing Body of Spatial Biology Research Presented at the 35th Annual Meeting of the Society of Immunotherapy of Cancer Conference (SITC)
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the highlights of more than 35 NanoString-related
Amex Reports Phase Two Metallurgical Results from Three Composite Samples from the HGZ at Perron – Confirms Gold Recovery of +99% - and Grants Stock Options
MONTREAL, CANADA – November 11, 2020 - Amex Exploration Inc. (“Amex or the Company”) (TSX-V: AMX, FRA: MX0, OTCQX: AMXEF) is very pleased to report additional metallurgical results from the
BioVaxys Announces 96.4 Percent Positive Antibody Immune Response Results from an In Vivo Murine Model Study of Its SARS-CoV-2 Vaccine
Vancouver, British Columbia, November 11, 2020 — BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB) (“BioVaxys”) is pleased to announce that results from its preclinical animal study (also known
Makara Provides Corporate Update
Vancouver, Canada, November 11, 2020 - Makara Mining Corp. (CSE: MAKA; FSE: MK0; OTC: MAKAF) (“Makara” or the “Company”) is pleased to provide the following corporate update on its three
Spodumene Concentrator Pilot Testwork Launched
- Pilot testwork will be completed on a 50t sample of ore collected from Piedmont’s Core Property
- SGS Canada will complete dense medium and flotation pilot work over the